Michael Holder - 01 Jun 2026 Form 4 Insider Report for MDxHealth SA (MDXH)

Reporting relationship: Director
Issuer ticker: MDXH
Reported as of: 01 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2026, 17:30:05 UTC
Prior SEC filing: 20 May 2026
Next SEC filing: 12 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph Sollee, as attorney-in-fact for Michael Holder

Key filing fact

Michael Holder filed Form 4 for MDxHealth SA (MDXH) on 03 Jun 2026.

Key facts

This page summarizes Michael Holder's Form 4 filing for MDxHealth SA (MDXH).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Jun 2026, 17:30.

Change

Previous filing in this sequence was filed on 20 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001515140 Primary reporting owner

Holder Michael

Relationship: Director
Address: CAP BUSINESS CENTER, ZONE INDUSTRIELLE DES HAUTS-SARTS, HERSTAL, BELGIUM
Signature: /s/ Joseph Sollee, as attorney-in-fact for Michael Holder
Signature date: 03 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDXH transaction Derivative

Share Option

Award

Transaction value
Shares: +10,000
Change %
Price: $0.000000^*
Shares after: 10,000
Date: 01 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 10,000
Exercise price: $0.7600
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $0.76 granted on June 1, 2026 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.